Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taraxacum officinale leaf, commonly known as dandelion leaf, is a botanical extract derived from the perennial herb *Taraxacum officinale*. While not an approved pharmaceutical drug, it is widely used in herbal medicine and dietary supplements. The extract contains a variety of bioactive compounds, including flavonoids such as luteolin, sesquiterpene lactones, and phenolic acids. It has been investigated for its potential diuretic, hepatoprotective, anti-inflammatory, and antidiabetic properties. Proposed mechanisms of action include the inhibition of alpha-glucosidase and alpha-amylase for blood glucose regulation, modulation of extracellular signal-regulated kinase (ERK) pathways in cancer research, and antioxidant-mediated liver protection. It is typically consumed as a tea, liquid extract, or in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taraxacum officinale leaf.